GeneDx Holdings/$WGS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GeneDx Holdings
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Ticker
$WGS
Sector
Primary listing
Employees
1,300
Headquarters
Website
GeneDx Holdings Metrics
BasicAdvanced
$2bn
-
-$2.69
1.97
-
Price and volume
Market cap
$2bn
Beta
1.97
52-week high
$170.87
52-week low
$32.21
Average daily volume
1.2m
Financial strength
Current ratio
3.088
Quick ratio
2.825
Long term debt to equity
64.167
Total debt to equity
66.185
Interest coverage (TTM)
-12.73%
Profitability
EBITDA (TTM)
-7.85
Gross margin (TTM)
69.56%
Net profit margin (TTM)
-17.58%
Operating margin (TTM)
-7.52%
Effective tax rate (TTM)
-0.43%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
-4.37%
Return on equity (TTM)
-30.42%
Valuation
Price to revenue (TTM)
4.413
Price to book
7.88
Price to tangible book (TTM)
18.63
Price to free cash flow (TTM)
-68.185
Free cash flow yield (TTM)
-1.47%
Free cash flow per share (TTM)
-0.99
Growth
Revenue change (TTM)
34.09%
Earnings per share change (TTM)
91.07%
3-year revenue growth (CAGR)
25.51%
3-year earnings per share growth (CAGR)
-59.27%
GeneDx Holdings News
AllArticlesVideos
WGS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
Newsfile Corp·2 days ago
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
Newsfile Corp·2 days ago
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
Newsfile Corp·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs